Cargando…
Muscle wasting in chronic kidney disease: the role of the ubiquitin proteasome system and its clinical impact
Muscle wasting in chronic kidney disease (CKD) and other catabolic diseases (e.g. sepsis, diabetes, cancer) can occur despite adequate nutritional intake. It is now known that complications of these various disorders, including acidosis, insulin resistance, inflammation, and increased glucocorticoid...
Autores principales: | Rajan, Vik R., Mitch, William E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259254/ https://www.ncbi.nlm.nih.gov/pubmed/17987322 http://dx.doi.org/10.1007/s00467-007-0594-z |
Ejemplares similares
-
Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting
por: Nury, David, et al.
Publicado: (2007) -
Myostatin Activates the Ubiquitin-Proteasome and Autophagy-Lysosome Systems Contributing to Muscle Wasting in Chronic Kidney Disease
por: Wang, Dong-Tao, et al.
Publicado: (2015) -
Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome()()
por: Sandri, Marco
Publicado: (2013) -
The ubiquitin proteasome system in glia and its role in neurodegenerative diseases
por: Jansen, Anne H. P., et al.
Publicado: (2014) -
Ubiquitin–proteasome system and the role of its inhibitors in cancer therapy
por: Aliabadi, Fatemeh, et al.
Publicado: (2021)